Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.
Neurology. 2021 Jan 26;96(4):e610-e618. doi: 10.1212/WNL.0000000000011207. Epub 2020 Nov 23.
Neurology. 2021.
PMID: 33229455
Free PMC article.
Clinical Trial.
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Mantegazza R, O'Brien FL, Yountz M, Howard JF Jr; REGAIN study group.
Mantegazza R, et al.
Ann Clin Transl Neurol. 2020 Aug;7(8):1327-1339. doi: 10.1002/acn3.51121. Epub 2020 Jul 22.
Ann Clin Transl Neurol. 2020.
PMID: 32700461
Free PMC article.
Clinical Trial.
Item in Clipboard
Prediction of Motor Failure Time Using An Artificial Neural Network.
Scalabrini Sampaio G, Vallim Filho ARA, Santos da Silva L, Augusto da Silva L.
Scalabrini Sampaio G, et al. Among authors: augusto da silva l.
Sensors (Basel). 2019 Oct 8;19(19):4342. doi: 10.3390/s19194342.
Sensors (Basel). 2019.
PMID: 31597304
Free PMC article.
Item in Clipboard
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group.
Howard JF Jr, et al.
Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20.
Lancet Neurol. 2017.
PMID: 29066163
Clinical Trial.
Item in Clipboard
Cite
Cite